FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Morphine sulfate 75 mg rectal suppository Has presentation strength denominator value False 1 Inferred relationship Some 1
    Morphine sulfate 75 mg rectal suppository Count of base of active ingredient False 1 Inferred relationship Some
    Dosulepin 15 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Dosulepin 15 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alendronic acid (as alendronate sodium) 933 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alendronic acid (as alendronate sodium) 933 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream Count of base of active ingredient False 1 Inferred relationship Some
    Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream Has concentration strength denominator value False 1 Inferred relationship Some 1
    Paracetamol 650 mg and pentazocine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Paracetamol 650 mg and pentazocine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely didanosine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 1
    Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Count of base of active ingredient False 1 Inferred relationship Some
    Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment Has concentration strength denominator value False 1 Inferred relationship Some 2
    Aspirin 2.5 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Aspirin 2.5 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Budesonide 200 microgram/actuation solution for inhalation Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Cyanocobalamin 500 microgram/actuation nasal spray Count of base of active ingredient False 1 Inferred relationship Some
    Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sterculia gum 620 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Sterculia gum 620 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Levobunolol hydrochloride 5 mg/mL eye solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Levobunolol hydrochloride 5 mg/mL eye solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Chlorpromazine hydrochloride 2 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Chlorpromazine hydrochloride 2 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline 1 mg/mL nasal solution Has concentration strength numerator value False 1 Inferred relationship Some 1
    Adrenaline 1 mg/mL nasal solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline 1 mg/mL nasal solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium chloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium chloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely meptazinol 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely meptazinol 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely didanosine 1 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1

    Start Previous Page 197 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start